NCT02316275 Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery
| NCT ID | NCT02316275 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cedars-Sinai Medical Center |
| Condition | Stress Urinary Incontinence |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2011-12 |
| Primary Completion | 2021-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2011-12 with a primary completion date of 2021-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
To determine the impact of unrestricted postoperative activity on intermediate- and long-term continence outcomes of mid-urethral sling surgery in women with stress urinary incontinence. To assess the natural return to baseline activity level when patients are unrestricted following mid-urethral sling surgery with or without concomitant anterior or posterior pelvic organ prolapse repair.
Eligibility Criteria
Inclusion Criteria: * Non-pregnant female * Self-reported stress urinary incontinence * Incontinence demonstrated on physical exam and/or by an urodynamics study * Planned mid-urethral sling surgery * Available for 2 years of follow-up * Willing and able to complete study assessments per the judgment of the treating clinician * Willing and able to provide written informed consent Exclusion Criteria: * Age \<18 years at time of enrollment * Concomitant prolapse surgery other than anterior colporrhaphy * Currently pregnant or \<12 months post-partum * Unable to read, write, or comprehend English
Contact & Investigator
Jennifer Anger, MD, MPH
📞 3103852992
Jennifer Anger, MD, MPH
PRINCIPAL INVESTIGATOR
Cedars-Sinai Medical Center
Frequently Asked Questions
Who can join the NCT02316275 clinical trial?
This trial is open to female participants only, aged 18 Years or older, studying Stress Urinary Incontinence. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02316275 currently recruiting?
Yes, NCT02316275 is actively recruiting participants. Visit ClinicalTrials.gov or contact Cedars-Sinai Medical Center to inquire about joining.
Where is the NCT02316275 trial being conducted?
This trial is being conducted at Beverly Hills, United States.
Who is sponsoring the NCT02316275 clinical trial?
NCT02316275 is sponsored by Cedars-Sinai Medical Center. The principal investigator is Jennifer Anger, MD, MPH at Cedars-Sinai Medical Center. The trial plans to enroll 50 participants.